Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rocepafant (LAU8080) 是一种血小板活化因子(PAF)拮抗剂,可减轻新生大鼠缺氧缺血性脑损伤。Rocepafant 抑制肿瘤坏死因子-Afa 介导的小鼠 L929 肿瘤细胞的细胞毒性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 530 | 现货 | ||
5 mg | ¥ 1,230 | 现货 | ||
10 mg | ¥ 1,830 | 现货 | ||
25 mg | ¥ 3,530 | 现货 | ||
50 mg | ¥ 4,800 | 现货 | ||
100 mg | ¥ 6,830 | 现货 |
产品描述 | Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells. |
靶点活性 | PAF receptor:0.74 nM |
体内活性 | Ten patients with active disease were treated for 4 weeks with a PAF receptor antagonist, BN 50730, given orally (40 mg twice daily). The treatment period was followed by a 4-week follow-up period. Clinical indicators of disease activity significantly improved during the treatment period, with a progressive return to baseline values during the follow-up period. No significant change in laboratory variables was observed. The tolerance of the treatment was excellent, and no clinical or laboratory evidence of side effects was recorded. These results must be confirmed in a controlled study, but suggest an anti-inflammatory effect.[4] |
别名 | LAU 8080, LAU8080, BN 50730, LAU-8080, BN50730, BN-50730 |
分子量 | 535.08 |
分子式 | C26H23ClN6OS2 |
CAS No. | 132579-32-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (102.79 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8689 mL | 9.3444 mL | 18.6888 mL | 46.722 mL |
5 mM | 0.3738 mL | 1.8689 mL | 3.7378 mL | 9.3444 mL | |
10 mM | 0.1869 mL | 0.9344 mL | 1.8689 mL | 4.6722 mL | |
20 mM | 0.0934 mL | 0.4672 mL | 0.9344 mL | 2.3361 mL | |
50 mM | 0.0374 mL | 0.1869 mL | 0.3738 mL | 0.9344 mL | |
100 mM | 0.0187 mL | 0.0934 mL | 0.1869 mL | 0.4672 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Rocepafant 132579-32-9 Others Platelet aggregation LAU 8080 LAU8080 BN 50730 LAU-8080 BN50730 BN-50730 Inhibitor inhibitor inhibit